Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEARCH: ATG-010 (Selinexor) in R/R DLBCL
NCT03992339Phase 2Completed
- Sponsor
- Antengene
- Start
- Apr 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in diffuse large B-cell lymphoma (DLBCL), sponsored by Antengene. Started Apr 2020; status: completed.
02
Drugs
selinexor
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03992339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03992339.